About Regenerative Medicines
Regenerative medicine deals with the process of using therapeutically induced or laboratory-grown human tissue to treat injured or diseased human cells, tissues, or organs. It focuses on repairing, replacing, or regenerating damaged cells, and thus offers a paradigm shift in healthcare treatment. The three main technologies used in regenerative medicine are small molecules and biologics, cell therapy, and gene therapy. Small molecules and biologics help in the regeneration of diseased cells and tissues. Whereas cell therapy helps in treating the functioning of the existing cells, gene therapy helps in the correction of defective genes of the body.
TechNavio's analysts forecast the Global Regenerative Medicine market to grow at a CAGR of 20.16 percent over the period 2014-2019.
Covered in this Report
The Global Regenerative Medicine market can be segmented into the following based on the type of application such as: Orthopedic Tendon and Ligament, Chronic and Acute Wounds, Plastic and Reconstructive Surgery, Cardiology, Breast Reconstruction, Osteoarthritis, Trauma, General Surgery, Hernia Repair, Burns, Urology, and Urogynecology.
TechNavio's report, Global Regenerative Medicine Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Regenerative Medicine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Baxter International
• Kinetic Concepts
• Medtronic
• Stryker
Other Prominent Vendors
• Aastrom Biosciences
• Acologix
• Advanced Cell Technology
• Arteriocyte
• Athersys
• Avita Medical
• Bacterin International
• Bellicum Pharmaceuticals
• Bioactive Regenerative Therapeutics
• BioCardia
• BioLife Solutions
• CryoLife
• Cynata Therapeutics
• Cytomedix
• Cytori Therapeutics
• Fibrocell Science
• Forticell Bioscience
• GE Healthcare
• Geron
• Histogenics
• Humacyte
• Integra Life Sciences
• InVivo Therapeutics
• Kensey Nash
• MaxCyte
• Mesoblast
• Nanofiber Solutions CTO
• NeoStem
• Neuralstem
• Olympus Terumo Biomaterials
• Opexa Therapeutics
• Organogenesis
• Osiris Therapeutics
• Osteotech
• Pluristem Therapeutics
• ReNeuron Group
• RTI Biologics
• SanBio
• StemCells
• Tengion
• Thermo Fischer Scientific
• Tissue Genesis
• ViaCyte
Market Driver
• Rise in Prevalence of Degenerative Diseases
• For a full, detailed list, view our report
Market Challenge
• Stringent Regulatory Approval Processes
• For a full, detailed list, view our report
Market Trend
• Increase in M&A
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
07.1 Global Orthopedic Tendon and Ligament in Regenerative Medicine Market
07.1.1 Market Size and Forecast
07.2 Global Chronic and Acute Wounds in Regenerative Medicine Market
07.2.1 Market Size and Forecast
07.3 Global Plastic and Reconstructive Surgery in Regenerative Medicine Market
07.3.1 Market Size and Forecast
07.4 Global Cardiology in Regenerative Medicine Market
07.4.1 Market Size and Forecast
07.5 Global Breast Reconstruction in Regenerative Medicine Market
07.5.1 Market Size and Forecast
07.6 Global Osteoarthritis in Regenerative Medicine Market
07.6.1 Market Size and Forecast
07.7 Global Trauma in Regenerative Medicine Market
07.7.1 Market Size and Forecast
07.8 Global General Surgery in Regenerative Medicine Market
07.8.1 Market Size and Forecast
07.9 Global Hernia Repair in Regenerative Medicine Market
07.9.1 Market Size and Forecast
07.10 Global Burns in Regenerative Medicine Market
07.10.1 Market Size and Forecast
07.11 Global Urology in Regenerative Medicine Market
07.11.1 Market Size and Forecast
07.12 Global Urogynecology in Regenerative Medicine Market
07.12.1 Market Size and Forecast
08. Market Segmentation by Technology
08.1 Global Small Molecules and Biologics in Regenerative Medicine Market
08.1.1 Market Size and Forecast
08.2 Global Cell Therapy in Regenerative Medicine Market
08.2.1 Market Size and Forecast
08.3 Global Gene Therapy in Regenerative Medicine Market
08.3.1 Market Size and Forecast
09. Geographical Segmentation
09.1 Regenerative Medicine Market in Americas
09.1.1 Market Size and Forecast
09.2 Regenerative Medicine Market in EMEA Region
09.2.1 Market Size and Forecast
09.3 Regenerative Medicine Market in APAC Region
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Baxter International
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Business Segmentation
18.1.4 Business Strategy
18.1.5 Revenue by Business Segmentation
18.1.6 Revenue by Geographical Segmentation
18.1.7 Key Developments
18.1.8 SWOT Analysis
18.2 Kinetic Concepts
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation
18.2.4 Business Segmentation by Revenue 2013
18.2.5 Sales by Geography
18.2.6 Business Strategy
18.2.7 Recent Developments
18.2.8 SWOT Analysis
18.3 Medtronic
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation
18.3.4 Revenue by Business Segmentation
18.3.5 Revenue Comparison by Business Segmentation 2012 and 2013
18.3.6 Revenue by Geographical Segmentation
18.3.7 Business Strategy
18.3.8 Key Developments
18.3.9 SWOT Analysis
18.4 Stryker
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2013
18.4.4 Business Segmentation by Revenue 2012 and 2013
18.4.5 Geographical Segmentation by Revenue 2013
18.4.6 Business Strategy
18.4.7 Recent Developments
18.4.8 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Global Regenerative Medicine Market by Application
Exhibit 2: Market Research Methodology
Exhibit 3: Global Regenerative Medicine Market 2015-2019 (US$ million)
Exhibit 4: Global Regenerative Medicine Market Segmentation by Application
Exhibit 5: Global Regenerative Medicine Market Segmentation by Application 2013
Exhibit 6: Global Orthopedic Tendon and Ligament in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 7: Global Chronic and Acute Wounds in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 8: Global Plastic and Reconstructive Surgery in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 9: Global Cardiology in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 10: Global Breast Reconstruction in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 11: Global Osteoarthritis in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 12: Global Trauma in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 13: Global General Surgery in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 14: Global Hernia Repair in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 15: Global Burns in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 16: Global Urology in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 17: Global Urogynecology in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 18: Global Regenerative Medicine Market by Application Segmentation 2014-2019
Exhibit 19: Global Regenerative Medicine Market by Application Segmentation 2014-2019 (US$ billion)
Exhibit 20: Global Regenerative Medicine Market Segmentation by Technology
Exhibit 21: Global Regenerative Medicine Market Segmentation by Technology 2014
Exhibit 22: Global Small Molecules and Biologics in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 23: Global Cell Therapy in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 24: Global Gene Therapy in Regenerative Medicine Market 2014-2019 (US$ billion)
Exhibit 25: Global Regenerative Medicine Market by Technology Segmentation 2014-2019
Exhibit 26: Global Regenerative Medicine Market by Technology Segmentation 2014-2019 (US$ billion)
Exhibit 27: Global Regenerative Medicine Market by Geographical Segmentation 2014
Exhibit 28: Regenerative Medicine Market in Americas 2014-2019 (US$ million)
Exhibit 29: Regenerative Medicine Market in EMEA Region 2014-2019 (US$ million)
Exhibit 30: Regenerative Medicine Market in APAC Region 2014-2019 (US$ million)
Exhibit 31: Global Regenerative Medicine Market by Geographical Segmentation 2014-2019
Exhibit 32: Global Regenerative Medicine Market by Geographical Segmentation 2014-2019 (US$ billion)
Exhibit 33: Baxter International Inc. : Business Segmentation
Exhibit 34: Baxter International Inc.: Revenue by Business Segmentation 2013
Exhibit 35: Baxter International Inc.: Revenue by Geographical Segmentation 2013
Exhibit 36: Kinetic Concepts: Business Segmentation 2013
Exhibit 37: Kinetic Concepts: Business Segmentation by Revenue 2013
Exhibit 38: Kinetic Concepts: Sales by Geography 2013
Exhibit 39: Medtronic Inc.: Business Segmentation
Exhibit 40: Medtronic Inc.: Revenue by Business Segmentation 2013
Exhibit 41: Medtronic Inc.: Revenue Comparison by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 42: Medtronic Inc.: Revenue by Geographical Segmentation 2013
Exhibit 43: Stryker: Business Segmentation by Revenue 2013
Exhibit 44: Stryker: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 45: Stryker: Geographical Segmentation by Revenue 2013
